|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 48/00 | (2006.01) |
| A61K 31/713 | (2006.01) | ||
| C12N 15/113 | (2010.01) | ||
| A61K 9/127 | (2006.01) | ||
| C12N 15/11 | (2006.01) |
| (11) | Number of the document | 2395012 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11169865.0 |
| Date of filing the European patent application | 2006-11-02 | |
| (97) | Date of publication of the European application | 2011-12-14 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-18 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 732964 P | 2005-11-02 | US | |
| 817933 P | 2006-06-30 | US |
| (72) |
MacLachan, Ian, CA
Judge, Adam, CA
|
| (73) |
Arbutus Biopharma Corporation,
25th Floor, 700 West Georgia Street, Vancouver BC V7Y 1B3,
CA
|
| (54) | Modified siRNA molecules and uses thereof |
| Modified siRNA molecules and uses thereof |